7,960 results match your criteria Transurethral Resection of the Prostate

The Efficacy and Safety of Laser and Electrosurgical Transurethral Procedures for the Treatment of BPO in High-Risk Patients: A Systematic Review.

Res Rep Urol 2022 17;14:247-257. Epub 2022 Jun 17.

Clinique Pasteur, Toulouse, France.

Objective: To compare efficacy and safety outcomes of GreenLight, Holmium and Thulium laser  techniques with standard monopolar and bipolar transurethral resection of the prostate (TURP) in high-risk patients with lower urinary tract symptoms (LUTS) secondary to benign prostatic obstruction (BPO).

Methods: We conducted a systematic literature review of studies in patients undergoing BPO surgeries who may be considered high-risk for standard TURP, with higher risk defined as follows: large prostates (≥80 mL) and/or taking antithrombotic agents and/or urinary retention and/or age >80 years and/or significant comorbidity.  Outcomes summarised included bleeding complications, re-intervention rates, hospital length of stay, and standard measures of disease and symptom severity for all available timepoints. Read More

View Article and Full-Text PDF

Application of Transurethral Prostate Resection Instrumentation for Treating Low Rectal Anastomotic Leakage: A Pilot Study.

Cancer Manag Res 2022 16;14:1987-1994. Epub 2022 Jun 16.

Institute of Urology, Hexi University, Zhangye, Gansu, 734000, People's Republic of China.

Purpose: To determine an accurate method of inspecting low anastomotic leakages and application of transurethral prostate resection instrumentation for treating low rectal anastomotic leakage.

Patients And Methods: Clinical data of eight patients treated for anastomotic leakage after rectal cancer surgery at Zhangye People's Hospital (affiliated to Hexi University), from August 2019 to November 2021, were retrospectively analyzed. Transanal prostate resection instrumentation was used to assess the leakage and surrounding conditions. Read More

View Article and Full-Text PDF

Benign prostatic hyperplasia surgical treatment trends in the Public Health System in São Paulo, Brazil.

Einstein (Sao Paulo) 2022 17;20:eAO6880. Epub 2022 Jun 17.

Hospital Israelita Albert Einstein, São Paulo, SP, Brazil.

Objective: To describe and compare the number of surgeries, mortality rate, length of hospital stay, and costs of transurethral resection of the prostate and open prostatectomy for the treatment of benign prostatic hyperplasia, between 2008 and 2018, in the Public Health System in São Paulo, Brazil.

Methods: Ecological and retrospective study using data from the informatics department of the Brazilian Public Health System database. Procedure codes were "open prostatectomy" and "transurethral resection of the prostate. Read More

View Article and Full-Text PDF

Symptomatic absorption of normal saline during transurethral resection of the prostate: a case report.

JA Clin Rep 2022 Jun 21;8(1):43. Epub 2022 Jun 21.

Department of Anesthesiology, Osaka City University Graduate School of Medicine, 1-5-7 Asahimachi, Abeno-ku, Osaka, 545-8586, Japan.

Background: Transurethral resection of the prostate (TUR-P) could incidentally cause hyponatremia, known as TUR syndrome due to intravascular absorption of non-electrolytic irrigation fluid. Recently, normal saline has been used as an irrigation fluid in a new system named TURis (TUR in saline) to prevent TUR syndrome. However, rapid massive absorption of normal saline can also cause other systemic adverse events. Read More

View Article and Full-Text PDF

Surgical Treatments of Benign Prostatic Hyperplasia and Prostate Cancer Stereotactic Radiotherapy: Impact on Long-Term Genitourinary Toxicity.

Clin Oncol (R Coll Radiol) 2022 Jun 14. Epub 2022 Jun 14.

Division of Radiation Oncology, Geneva University Hospital, Geneva, Switzerland; Faculty of Medicine, Geneva University, Geneva, Switzerland. Electronic address:

Aims: Although the results on acute and late toxicity of ultrahypofractionation are encouraging, data on safety in prostate cancer patients with a medical history of transurethral resection of the prostate (TURP) or adenomectomy remain scarce, especially in cases of repeated procedures. The aim of the present study was to report on long-term toxicities after stereotactic body radiotherapy (SBRT) of prostate cancer patients with previous surgical treatment of benign prostatic hyperplasia.

Materials And Methods: Among 150 patients treated with SBRT (median dose 36. Read More

View Article and Full-Text PDF

Prostate cancer metastasis mimicking a primary urothelial carcinoma of the bladder.

J Surg Case Rep 2022 Jun 14;2022(6):rjac275. Epub 2022 Jun 14.

Department of Urology, Princess Royal University Hospital, King's College Hospital NHS Foundation Trust Farnborough Common, London BR6 8ND, UK.

We report on a 79-year-old male patient who presented with asymptomatic elevation of prostate-specific antigen and a concurrent papillary lesion, which raised the suspicion of synchronous bladder and prostatic malignancies. He underwent a trans-perineal prostate biopsy as well as transurethral resection of bladder tumour, which revealed a Gleason 9 adenocarcinoma of prostatic origin. While synchronous bladder and prostate cancer is a possibility, differential diagnosis in a patient presenting with lesions of the bladder neck should include advanced prostate cancer. Read More

View Article and Full-Text PDF

Does prior transurethral resection of prostate have a negative impact on the outcome of holmium laser enucleation of prostate? Results from a prospective comparative study.

Urol Ann 2022 Apr-Jun;14(2):118-124. Epub 2022 Feb 17.

Department of Urology, University of Miami, Miller School of Medicine, Miami, Florida, USA.

Objectives: To prospectively evaluate safety and efficacy of holmium laser enucleation of prostate (HoLEP) for surgical treatment of recurrent symptoms due to prostatomegaly after prior transurethral resection of prostate (TURP).

Materials And Methods: We prospectively evaluated 43 patients with a history of TURP who underwent HoLEP (study group). Patients in chronological order who underwent HoLEP without prior TURP were included in the control group. Read More

View Article and Full-Text PDF
February 2022

The significance of the extent of tissue embedding for the detection of incidental prostate carcinoma on transurethral prostate resection material: the more, the better?

Virchows Arch 2022 Jun 17. Epub 2022 Jun 17.

Department of Urology, University Hospital Frankfurt, Goethe University Frankfurt am Main, Frankfurt/Main, Germany.

The aim of this study is to investigate the incidental prostate cancer (iPCa) detection rates of different embedding methods in a large, contemporary cohort of patients with bladder outlet obstruction (BOO) treated with transurethral surgery. We relied on an institutional tertiary-care database to identify BOO patients who underwent either transurethral loop resection or laser (Holmium:yttrium-aluminium garnet) enucleation of the prostate (HoLEP) between 01/2012 and 12/2019. Embedding methods differed with regard to the extent of the additional prostate tissue submitted following the first ten cassettes of primary embedding (cohort A: one [additional] cassette/10 g residual tissue vs. Read More

View Article and Full-Text PDF

Evaluating Factors That Influence Healthcare Resource Utilization in Transurethral Resection of Prostate.

J Endourol 2022 Jun 16. Epub 2022 Jun 16.

University of Kentucky Medical Center, 12253, Urology, 800 Rose St., Room MS237, Lexington, Kentucky, United States, 40536-0293;

Introduction: Transurethral resection of prostate (TURP) remains the gold standard for treatment of benign prostatic hyperplasia (BPH) but is associated with complications. The association of healthcare resource utilization (HRU) and TURP has been poorly studied. We seek to evaluate HRU in patients undergoing TURP and identify factors contributing to outcomes. Read More

View Article and Full-Text PDF

Unexpected encapsulated hematoma after Rezum therapy: First outcome of an emerging therapy.

Urol Case Rep 2022 Sep 4;44:102125. Epub 2022 Jun 4.

Department of Urology, King Fahad Medical City, Riyadh, Saudi Arabia.

Rezum therapy is in emerging minimally invasive treatment for BPH. Complications of Rezum are underreported in the literature. We report a case of a 61-year-old male patient who presented to ED two months after Rezum with hematuria and clot retention. Read More

View Article and Full-Text PDF
September 2022

Bipolar radiofrequency thermotherapy vs. transurethral resection of the prostate: Effect on nocturia as a result of benign prostatic obstruction.

Can Urol Assoc J 2022 Jun 9. Epub 2022 Jun 9.

Department of Urology, Lokman Hekim University, Ankara, Turkey.

Introduction: The purpose of this study was to investigate and compare the effects of radiofrequency thermotherapy (RF) thermotherapy and transurethral resection of the prostate (TURP) on nocturia and associated quality of life in patients diagnosed with benign prostatic obstruction (BPO) under medical treatment who have complaints of persistent nocturia.

Methods: The results of patients who underwent RF thermotherapy and TURP procedures between February 2019 and February 2022 were examined, and their three-month results were compared based on their uroflowmetry values, International Prostate Symptom Score (IPSS) values, nocturia frequency, and Nocturia Quality of Life Questionnaire scores.

Results: While the frequency of nocturia in the RF thermotherapy group that was 4. Read More

View Article and Full-Text PDF

Predictive value of voiding efficiency after active void trial in men undergoing BPH surgery.

Urology 2022 Jun 10. Epub 2022 Jun 10.

Department of Urology, David Geffen School of Medicine, University of California, Los Angeles.

Objectives: To determine the predictive value of voiding efficiency on acute urinary retention after discharge from BPH surgery.

Materials And Methods: We performed a prospective observational cohort study of three surgeons' practices from 2019 to present. All men included underwent trial of void on postoperative day 1 after transurethral resection of prostate (TURP) or Holmium enucleation of prostate (HoLEP). Read More

View Article and Full-Text PDF

Prostatic arterial embolization for men with benign prostatic hyperplasia: Cochrane review.

BJU Int 2022 Jun 13. Epub 2022 Jun 13.

Department of Urology, University of Minnesota, Minneapolis, Minnesota, USA.

Objectives: To assess the effects of prostatic arterial embolization (PAE) compared to other procedures for treatment of lower urinary tract symptoms (LUTS) in men with benign prostatic hyperplasia (BPH).

Methods: We included randomized controlled trials (RCTs), as well as non-randomized studies (NRSs) enrolling men with BPH undergoing PAE versus other surgical interventions via a comprehensive search up until 8 Nov 2021. Two independent reviewers screened the literature, extracted data, assessed risk of bias, performed statistical analyses by using a random-effects model, and rated the certainty of evidence (CoE) of RCTs and NRSs. Read More

View Article and Full-Text PDF

Bladder spasms following ambulatory urologic procedures.

Can J Urol 2022 Jun;29(3):11175-11181

Departments of Anesthesiology and Perioperative Medicine, Mayo Clinic College of Medicine and Science, Rochester, Minnesota, USA.

Introduction: Bladder spasm are common complications following cystoscopic urologic procedures. This study aims to determine the incidence and risk factors for bladder spasm after ambulatory cystoscopic urologic procedures.

Materials And Methods: Medical records of adult patients who underwent urologic procedures in our ambulatory center from May 1st, 2018 through December 30th, 2020, were reviewed. Read More

View Article and Full-Text PDF

Two-Staged Sacral Neuromodulation for the Treatment of Nonobstructive Urinary Retention: A Multicenter Study Assessing Predictors of Success.

Neuromodulation 2022 Jun 9. Epub 2022 Jun 9.

Department of Urology, Erasmus Medical Center, Rotterdam, Zuid-Holland, The Netherlands.

Objectives: The aims of this study were to 1) determine the success rate of the tined lead test phase in patients with nonobstructive urinary retention (NOUR), 2) determine predictive factors of a successful test phase in patients with NOUR, and 3) determine long-term treatment efficacy and satisfaction in patients with NOUR.

Materials And Methods: The first part was a multicenter retrospective study at two centers in The Netherlands. Patients with NOUR received a four-week tined lead test phase. Read More

View Article and Full-Text PDF

Pharmacotherapy vs. minimally invasive therapies as initial therapy for moderate-to-severe benign prostatic hyperplasia: a cost-effectiveness study.

Prostate Cancer Prostatic Dis 2022 Jun 10. Epub 2022 Jun 10.

Division of Urology Krembil Research Institute, University Health Network, Toronto, ON, Canada.

Background: Recently, minimally invasive therapies (MITs), such as water vapor thermal therapy (WVTT) and prostatic urethral lift (PUL) have become an alternative to surgery or pharmacotherapy to manage benign prostatic hyperplasia (BPH), offering symptom relief with a favorable safety profile. The objective of this study was to evaluate the cost-utility of MITs (WVTT and PUL) compared to pharmacotherapy as initial treatment for patients with moderate-to-severe BPH.

Methods: In this model-based economic evaluation we simulated BPH progression in men (mean age 65 years, average International Prostate Symptom Score 16. Read More

View Article and Full-Text PDF

Estrogen and G protein-coupled estrogen receptor accelerate the progression of benign prostatic hyperplasia by inducing prostatic fibrosis.

Cell Death Dis 2022 Jun 7;13(6):533. Epub 2022 Jun 7.

Department of Urology, Peking University First Hospital, 100034, Beijing, China.

Benign prostatic hyperplasia (BPH) is the most common and progressive urological disease in elderly men worldwide. Epidemiological studies have suggested that the speed of disease progression varies among individuals, while the pathophysiological mechanisms of accelerated clinical progression in some BPH patients remain to be elucidated. In this study, we defined patients with BPH as belonging to the accelerated progressive group (transurethral resection of the prostate [TURP] surgery at ≤50 years old), normal-speed progressive group (TURP surgery at ≥70 years old), or non-progressive group (age ≤50 years old without BPH-related surgery). Read More

View Article and Full-Text PDF

Management about intravesical histological transformation of prostatic mucinous carcinoma after radical prostatectomy: A case report.

World J Clin Cases 2022 May;10(14):4654-4660

Department of Urology, Institute of Urology, West China Hospital of Sichuan University, Chengdu 610041, Sichuan Province, China.

Background: Prostatic mucinous carcinoma (MC) and prostatic signet ring cell carcinoma are two variants of prostate cancer. MC has a higher overall survival time among all variants, while signet ring cell carcinoma is associated with lower survival time relative to other carcinomas. Only a small proportion of prostatic MC may contain signet ring cells. Read More

View Article and Full-Text PDF

Hemangioma of the prostate with retrograde ejaculation - a case report.

Int J Surg Case Rep 2022 May 19;94:107102. Epub 2022 Apr 19.

Department of Andrology, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, Guangdong, China. Electronic address:

Introduction And Importance: Hemangioma of the prostate is rarely reported. We here describe a hemangioma of the prostate in a 31-year-old man.

Case Presentation: The history, imaging characteristics, treatment and one year follow-up results were well documented. Read More

View Article and Full-Text PDF

The Effect of Transurethral Resection of the Prostate on Erectile and Ejaculatory Functions in Patients with Benign Prostatic Hyperplasia.

Urol Int 2022 Jun 2:1-8. Epub 2022 Jun 2.

Clinical Nursing Department, School of Nursing, The University of Jordan, Amman, Jordan.

Introduction: The aim of this study was to investigate the effect of TURP on erectile function (EF) and ejaculatory function (EJF).

Methods: A total of 91 patients who underwent TURP were retrospectively assessed. Patients were divided into two groups based on International Index of Erectile Function (IIEF-5): group A included 41 patients with normal EF, and group B included 50 patients with erectile dysfunction (ED). Read More

View Article and Full-Text PDF

Efficacy and Safety of Transurethral Enucleation with Bipolar Energy for the Treatment of Benign Prostatic Hyperplasia: Does Prostate Volume Matter?

J Nippon Med Sch 2022 May 30. Epub 2022 May 30.

Department of Urology, Nippon Medical School, Tokyo, Japan.

Background: We evaluated whether the efficacy and safety of transurethral enucleation with bipolar energy (TUEB) is affected by prostate volume (PV) in the treatment of benign prostatic hyperplasia (BPH).

Methods: We retrospectively evaluated 180 patients with symptomatic BPH who underwent TUEB between 2008 and 2015. Efficacy was assessed by perioperative changes in the international prostate symptom score (IPSS), Quality of Life Score (QOLS), maximum flow rate on uroflowmetry (Qmax), and serum prostate-specific antigen level (PSA), which were recorded at 3 months postoperative. Read More

View Article and Full-Text PDF

[Interpretation of biopsy material after transuretral and laser en bloc resection of non-muscle-invasive bladder cancer].

Arkh Patol 2022 ;84(3):32-39

Lomonosov Moscow State University, Moscow, Russia.

Bladder cancer is one of the most common onco-urological diseases, ranked second in frequency among all tumors of the urinary system after prostate cancer. At the time of detection of the primary tumor, approximately 75% of patients have no invasion into the muscularis layer (non-muscle-invasive carcinoma), with tumor growth limited to the basal membrane (stage Ta) or submucosal base (stage T1). Removal of the tumor in a «unified block» (laser en-bloc resection or L-ERBT), unlike routine transurethral resection, allows to obtain qualitative biopsy material for precise pathomorphological staging of the tumor process. Read More

View Article and Full-Text PDF

Hemoperitoneum after transperineal prostate biopsy.

Medicina (B Aires) 2022 ;82(3):452-455

Servicio de Urología, Hospital Alemán de Buenos Aires, Argentina.

Bleeding is the most common complication after a prostate biopsy, commonly self-limited. We describe a case of a patient who developed a hemoperitoneum after a transperineal prostate biopsy. A 65-year-old man with a history of prostate cancer diagnosed in 2016 by transurethral resection, with no further urologic control until 2020 when a rise in the serum prostate-specific antigen was diagnosed: 4. Read More

View Article and Full-Text PDF

Analgesic Effects of Dexmedetomidine Combined with Spinal and Epidural Anesthesia Nursing on Prostate Hyperplasia Patients after Transurethral Resection of Prostate by Intelligent Algorithm-Based Magnetic Resonance Imaging.

Comput Math Methods Med 2022 21;2022:4243244. Epub 2022 May 21.

Department of Anesthesia Surgery, Changsha Fourth Hospital, Changsha, 410006 Hunan, China.

To analyze the investigation of the application effects of different doses of dexmedetomidine (Dex) with combined spinal and epidural anesthesia nursing on analgesia after transurethral resection of prostate (TURP) by intelligent algorithm-based magnetic resonance imaging (MRI), MRI imaging segmentation model of mask regions with convolutional neural network (Mask R-CNN) features was proposed in the research. Besides, the segmentation effects of Mask R-CNN, U-net, and V-net algorithms were compared and analyzed. Meanwhile, a total of 184 patients receiving TURP were selected as the research objects, and they were divided into A, B, C, and D groups based on random number table method, each group including 46 cases. Read More

View Article and Full-Text PDF

Morphometric Analysis of Prostate Zonal Anatomy After Transurethral Resection of Prostate and Holmium Laser Enucleation of Prostate Using Magnetic Resonance Imaging: A Pilot Study.

Turk J Urol 2022 May;48(3):201-208

Department of Radiology, University of Miami Miller Faculty of Medicine, Miami, FL.

Objective: The primary purpose was to compare the completeness of adenomectomy and zonal anatomy of prostate on magnetic resonance imaging prostate after transurethral resection of prostate and Holmium enucleation of prostate. The secondary purpose was to investigate the relationship between preoperative total prostate volume and postoperative transition zone and peripheral zone volume after both procedures.

Material And Methods: A retrospective review of all patients who underwent transurethral resection of pros- tate or Holmium enucleation of prostate over 3 years (2017-2020) and had at least 1 postoperative magnetic resonance imaging prostate was performed. Read More

View Article and Full-Text PDF

The P.R.OS.T.A.T.E Nomogram for the Preoperative Prediction of Clinical Efficacy of Transurethral Resection of the Prostate in Benign Prostatic Hyperplasia Patients.

Clin Interv Aging 2022 23;17:845-855. Epub 2022 May 23.

Department of Urology, Guizhou Provincial People's Hospital, Guiyang, People's Republic of China.

Purpose: Transurethral resection of the prostate (TURP) is often indicated for benign prostatic hyperplasia (BPH). Some patients, however, fail to adequately respond to these interventions. Accordingly, a powerful prediction model for TURP efficacy is warranted. Read More

View Article and Full-Text PDF

What is the role of minimally invasive surgical treatments for benign prostatic enlargement?

BMJ 2022 05 25;377:e069002. Epub 2022 May 25.

Minneapolis VAMC, Urology Section and Department of Urology, University of Minnesota, Minneapolis, USA.

View Article and Full-Text PDF

Male Breast Metastasis: A Case of Treatment-Emergent Neuroendocrine Prostate Cancer.

Cureus 2022 Apr 19;14(4):e24283. Epub 2022 Apr 19.

Internal Medicine, Hospital Prof. Doutor Fernando Fonseca, Amadora, PRT.

Treatment-emergent transformed neuroendocrine prostate cancer (NEPC) is a highly aggressive type of prostate cancer that may arise from typical adenocarcinoma of the prostate, which is associated with rapidly progressive disease involving visceral sites and refractoriness to hormonal therapy. We present the case of a 74-year old male with a known history of stable prostate adenocarcinoma treated with transurethral prostate resection, local radiotherapy (RT), and androgen deprivation therapy (ADT) in 2020 who presented to the emergency room with complaints of shoulder and anterior chest pain, dyspnoea, and fatigue. Upon examination, a solid, adherent breast mass and infra-clavicular adenopathy were palpable. Read More

View Article and Full-Text PDF

Case report and empirical review of intravesical explosion during transurethral resection of prostate.

Asian J Surg 2022 May 19. Epub 2022 May 19.

Department of Robotic Minimally Invasive Surgery Center, Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital & Affiliated Hospital of the University of Electronic Science and Technology of China, Chengdu, 610072, China. Electronic address:

View Article and Full-Text PDF